Results 1 to 10 of about 6,033 (218)

Alkaloids in Chelidonium majus L: a review of its phytochemistry, pharmacology and toxicology [PDF]

open access: yesFrontiers in Pharmacology
Chelidonium majus L. (C. majus), commonly known as “Bai Qu Cai” in China, belongs to the genus Chelidonium of the Papaveraceae family. It has rich medicinal value, such as alleviating coughs, asthma, spasms and pain. Recent studies have demonstrated that
Xin-Lan Li   +4 more
doaj   +4 more sources

Investigation of in vitro Cytotoxicity of Chelidonium majus against Leishmania Major [PDF]

open access: yesArchives of Razi Institute, 2022
One of the public health issues in the endemic areas, especially in the Middle East region would be the Leishmaniasis. The suggested cure for leishmaniasis is pentavalent antimonials.
K Madjeed Haddao   +9 more
doaj   +2 more sources

Integration of metabolomics and transcriptomics reveals the therapeutic mechanism underlying Chelidonium majus L. in the treatment of allergic asthma [PDF]

open access: yesChinese Medicine
Background Chelidonium majus is a well-known traditional Chinese medicine, and has been reported of the effect in relieving cough and asthma. However, the mechanism of action is still unknown.
Renguang Wang   +8 more
doaj   +2 more sources

Species-Specific Plant-Derived Nanoparticle Characteristics [PDF]

open access: yesPlants, 2022
Medicinal and agricultural plants contain numerous phytochemical compounds with pronounced biological effects on human health. They are known to encapsulate most of their characteristic bioactive compounds within membranous elements of intercellular ...
Akvilė Viršilė   +5 more
doaj   +2 more sources

Therapeutic effect of Chelidonium majus hydro-alcoholic extract alone and in combination with oxaliplatin on ovarian cancer cell line [PDF]

open access: yesDiscover Oncology
Ovarian cancer (OC) is the leading cause of tumor-related deaths among gynecologic cancers. Patients diagnosed with advanced stages of OC urgently require effective therapeutic interventions, but current therapies often fail in patients with recurrent ...
Zahra Hashempour   +7 more
doaj   +2 more sources

Romanian Wild-Growing Chelidonium majus—An Emerging Approach to a Potential Antimicrobial Engineering Carrier System Based on AuNPs: In Vitro Investigation and Evaluation [PDF]

open access: yesPlants
Novel nanotechnology based on herbal products aspires to be a high-performing therapeutic platform. This study reports the development of an original engineering carrier system that jointly combines the pharmacological action of Chelidonium majus and ...
Adina-Elena Segneanu   +9 more
doaj   +2 more sources

A chromosome-level genome assembly of the Chinese herbal medicine Chelidonium majus [PDF]

open access: yesScientific Data
Chelidonium majus is a herbaceous plant of significant medicinal value, which has been widely distributed in Europe, Asia, and Northern Africa. However, its genome remains uncharacterized.
Xialian Bu   +12 more
doaj   +2 more sources

Chelidonium majus WATER EXTRACT INITIATES PLATELET AGGREGATION AND INHIBITS FIBRIN POLYMERIZATION IN BLOOD PLASMA [PDF]

open access: yesBiotechnologia Acta, 2022
Chelidonium majus is a well-known source of biologically active compounds. Most of them are alkaloids, which are used in researches and for tradition medicine. In this study, we explored the influence of C.
R. Yu. Marunych   +6 more
doaj   +1 more source

Effectiveness of Volatile Natural Deep Eutectic Solvents (VNADESs) for the Green Extraction of Chelidonium majus Isoquinoline Alkaloids

open access: yesMolecules, 2022
The Chelidonium majus plant is rich in biologically active isoquinoline alkaloids. These alkaline polar compounds are isolated from raw materials with the use of acidified water or methanol; next, after alkalisation of the extract, they are extracted ...
Maciej Strzemski   +9 more
doaj   +1 more source

The Study of the Neuroprotective Effect of the Extract from Chelidonium Majus L. in Vitro

open access: yesActa Biomedica Scientifica, 2019
The protection of neurons from damage and death is an important challenge in the development of treatment of brain ischemia and neurodegenerative diseases.
A. Zhalsrai, L. Ts. Sanzhieva
doaj   +1 more source

Home - About - Disclaimer - Privacy